Skip to main content

Table 3 Proportion of dogs showing Flea Allergy Dermatitis signs at the initial visit and 12 week recheck following treatment with either topical fluralaner or a positive control

From: A randomized, blinded, controlled USA field study to assess the use of fluralaner topical solution in controlling canine flea infestations

Sign   Fluralaner topical solution Fipronil/(S)-methoprene spot-on solution
Erythema Number of dogs with sign at initial exam that were also eligible for re-examination at 12 weeks 58 25
% of dogs with lesion resolved at 12-week re-examination 91.4 60.0
Alopecia Number of dogs with sign at initial exam that were also eligible for re-examination at 12 weeks 43 19
% of dogs with lesion resolved at 12-week re-examination 86.0 78.9
Papules Number of dogs with sign at initial exam that were also eligible for re–examination at 12 weeks 32 6
% of eligible dogs with lesion resolved at 12-week re-examination 96.9 100.0
Scales Number of dogs with sign at initial exam that were also eligible for re-examination at 12 weeks 27 11
% of eligible dogs with lesion resolved at 12-week re-examination 92.6 72.7
Crusts Number of dogs with sign at initial exam that were also eligible for re-examination at 12 weeks 28 10
% of eligible dogs with lesion resolved at 12-week re-examination 100.0 80.0
Excoriation Number of dogs with sign at initial exam that were also eligible for re-examination at 12 weeks 25 6
% of eligible dogs with lesion resolved at 12-week re-examination 100.0 83.3